Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Switch to FNB Business

Product shop

By Turnover

First Business Zero (R0 - R5 million p.a) Gold Business (R0 - R5 million p.a) Platinum Business (R5 million - R60 million p.a) Enterprise Business (R60 million - R150 million+ p.a)

Transact

Business Accounts Credit Cards Cash Solutions Merchant Services eWallet Pro Staffing Solutions ATM Solutions Ways to bank Fleet Services Guarantees

Savings and Investments

Save and Invest 3PIM (3rd Party Investment Manager)

Borrow

FNB Cash Advance Overdraft Loans Debtor Finance Leveraged Finance Private Equity Securities Based Lending Selective Invoice Discounting Asset Based Finance Alternative Energy Solutions Commercial Property Finance Fleet Services

Insure

Insurance

For my employees

Staffing Solutions Employee benefits

Forex + Trade

Foreign Exchange Imports and exports Structured Trade + Commodity Finance Business Global Account (CFC account)

Value Adds + Rewards

Connect my business the dti initiatives Enterprise and supplier development Business Hub eBucks Rewards for Business DocTrail™ CIPC Integration Channel Instant Accounting Solutions Instant Payroll Instant Cashflow Instant Invoicing SLOW 24/7 Business Desk FNB Business Fundaba nav» Marketplace Prepaid products Accounting integrations

Industry Expertise

Philanthropy Chinese Business Islamic Banking Agriculture Public Sector Education Healthcare Franchise Motor Dealership Tourism

Going Global

Global Commercial Banking

Financial Planning

Overview

Bank Better

KYC / FICA Debit order + recipient switching Electronic Alerts

Corporates + Public Sector

Corporate Public Sector

All savings + investment accounts


Cash deposits

Notice deposits Immediate access Access to a portion Fixed deposits

Share investing

Shares

Tax-free investing

Tax-free accounts

Funds/unit trusts

Ashburton specialised products

Invest abroad

Offshore products

I want to save for

Personal goals Child's education Emergencies Tax-free

Compare similar

Compare

Additional options

Show me all Help me chosse Find an advisor

Financial planning

Overview

Back

Trade Ideas

Local Trade Idea: Netcare Limited (NTC) - BUY

 

By Peet Serfontein & Pritu Makan

We initiate a long position. Our upside target is set at R16. We recommend a stop-loss at R13.40.

Netcare operates the largest private hospital network in South Africa. The group also offers primary healthcare, sub-acute care, day surgery, occupational health and employee wellness services through Medicross, emergency medical services through Netcare 911, renal dialysis through National Renal Care and mental health and psychiatric services through Akeso. Netcare is also a leading private trainer of emergency medical and nursing personnel in the country.

The group boasts a market-leading position in South Africa with a defensive portfolio that has been augmented by the addition of mental health facilities as well - a noteworthy competitive advantage. Thematically, we like the hospital space in South Africa with a rising middle class likely to support long-term growth in demand for quality healthcare.

Technically, a double-bottom pattern in the share price makes for an appealing long position (see insert on main chart). The pattern reflects a shift in market sentiment, where selling pressure weakens, and buyers begin to re-enter at a perceived value area.

The start of upside momentum, according to the Moving Average Convergence Divergence (MACD) histogram indicator, supports the trade idea. When the MACD histogram shifts from negative to positive territory or begins to print higher bars while still below the zero line, it suggests that the rate of decline is slowing and that a potential bullish crossover may be forming. This early signal of strengthening momentum often precedes an actual price breakout, giving investors a lead indication of a possible reversal or continuation to the upside.

The price is in the accumulation phase of the Wyckoff Price Cycle, further supporting a bullish tone.

We suggest a medium capital at-risk allocation to this trade. Increase exposure for a break above R14.50.

Share Information
Share Code NTC
Industry Health Care Equipment & Services
Market Capital (ZAR) 19.57 billion
One Year Total Return 29.19%
Return Year-to-Date -1.25%
Current Price (ZAR) 14.34
52 Week High (ZAR) 15.77
52 Week Low (ZAR) 11.02
Financial Year End September
While the share has sold off heavily since the start of the year, a recovery can continue with several technical indicators supporting further upside momentum. The share is also testing its 200-day simple moving average.

Consensus Expectations (Bloomberg)
FY24 FY25E FY26E FY27E
Headline Earnings per Share (ZAR) 1.12 1.32 1.51 1.68
Growth (%) 17.95 14.16 11.41
Dividend Per Share (ZAR) 0.70 0.84 0.95 1.08
Growth (%) 20.14 13.32 13.43
Forward PE (times) 10.86 9.51 8.54
Forward Dividend Yield (%) 5.86 6.65 7.54
Solid earnings growth is expected over the forecast horizon, complimented by a relatively attractive dividend yield.

Buy/Sell Rationale:

Technical Analysis:

    • The lower panel shows the bullish trend period for the share (measured in weeks). Flat and sideways price movement is usually supportive of a bullish case given that it represents a phase of consolidation, which can serve as a base for the next leg higher.
    • The recent upwards trajectory of the On-balance volume indicator - which uses volume-flow to predict share price movements - supports our bullish stance. Furthermore, a trough in the Coppock Curve also supports a bullish case for a share by signalling the potential beginning of a long-term uptrend.
    • Our entry range is between R13.80 to R14.50. Our upside target is set at R16 (+13.2% from current levels).
    • Time to exit is mid-July 2025. Keep the option open to close the trade if the price reaches our profit target in a shorter time.
    • A price below R13.40 (-5.2% from current levels) is a major concern for downside potential and is recommended as a stop-loss.

Long-term fundamental view:

    • Netcare holds a market-leading position in the healthcare industry. The company has defensive qualities and increased exposure to the high-growth mental health space is expected to complement growth and add further defensiveness to the business.
    • Based on the recent 1H25 update, the group has seen solid upside this financial year so far with total paid patient days (PPDs) improving significantly on 1H24. This was mainly due to a recovery in the acute hospital division on the back of higher activity levels, which helped to offset a pullback in mental health services - adversely impacted by a temporary unavailability of beds at certain high occupancy sites.
    • The outlook statement was encouraging, with full-year PPDs expected to improve significantly compared to FY24, while revenue guidance at the time was in line with expectations.
    • Increased activity and operational efficiencies are expected to support further EBITDA margin expansion, improved earnings, and a higher return on invested capital.
    • Risks to our fundamental view include regulatory risk, insurance plan changes and competition. Additionally, growth is likely to slow near term as job creation remains subdued (therefore medical aid membership is rising at a slower pace). We are also concerned over PPD and admissions growth, with medical schemes becoming stricter when approving hospital stays.
    • The introduction of the NHI may theoretically be positive for hospitals because of higher occupancies, and this will drive top-line growth and have a positive impact on margins. However, it could still be detractive to profitability depending on pricing dynamics.

Share Name and Position MRP - BUY
(Continue to hold)
GRT - BUY
(Continue to hold)
ABG - Buy
(Continue to hold)
Entry 219.84 13.22 171.50
Current 239.26 13.09 165.98
Movement +8.8% -1% -3.2%
The start of wave 5 in the Elliott wave price theory remains of interest. Remains just below its 200-day simple moving average. Fading downside momentum supports the trade strategy.

Our profit target is at R267 with a trailing stop-loss at R221. Exit the trade on 9 June 2025.
The price is at one of the highest price bins out of the price distribution analysis remains of interest. Continues to test its 200-day simple moving average. Upside momentum supports the trade strategy.

Our profit target is at R16 with a trailing stop-loss at R12. Exit the trade on 17 November 2025.
A favourable peer comparison for the share remains of interest. Remains just below its 200-day simple moving average. Fading downside momentum supports the trade strategy.

Our profit target is at R200 with a trailing stop-loss at R160. Exit the trade on 14 July 2025.

FNB Stockbroking and Portfolio Management (Pty) Ltd, a subsidiary of FirstRand Bank Limited, an authorised Financial Services Provider and authorised user of the JSE limited (Reg no: 1996/011732/07). This Publication note is issued by FNB Stockbroking and Portfolio Management (Pty) Ltd for the information of clients only and should not be produced in whole or part without prior permission. Although FNB Stockbroking and Portfolio Management (Pty) Ltd is an Authorised Financial Services Provider, any opinions and/or analysis contained in this Publication are for informational purposes only and should not be considered advice, including but not limited to financial, legal or tax advice, or a recommendation to invest in any security or to adopt any investment strategy. The information contained herein has been obtained from sources/persons which we believe to be reliable but is not guaranteed for correctness, completeness or otherwise and we do not assume liability for loss arising from errors in the information or that may be suffered from using or relying on the information contained herein irrespective of whether there has been any negligence by us, our affiliates or any other employees of us, and whether such losses be direct or consequential. As market and economic conditions are subject to rapid change, any comments, opinions, and analysis is rendered as of the date of publishing and may change without notice. Such changes may have a material impact on the outcome of any investment. Securities involve a degree of risk and are volatile instruments. Past performance is not indicative of future performances. Securities or financial instruments mentioned in the Publication note may not be suitable for all investors and FNB Stockbroking and Portfolio Management (Pty) Ltd has bares no responsibility whatsoever arising from or as a consequence hereof. The material is not intended as a complete analysis of every material fact regarding any share, instrument, sector, region, market, country, investment, or strategy. The recipient of this Publication must make their own investment decision and is advised to contact his relationship manager for a personal financial analysis prior to making any investment decisions. Copyright 2018 by FNB Stockbroking and Portfolio Management (Pty) Ltd.

How would you like to log in?